There are a large number of ASX dividend stocks on the Australian share market that could be great candidates for income investors.
But which ones do analysts believe you should be buying now?
Let's look at three stocks that they are feeling bullish on:
ANZ Group Holdings Ltd (ASX: ANZ)
ANZ could be an ASX dividend stock to buy according to analysts at Goldman Sachs.
The broker currently has a buy rating and $26.66 price target on the banking giant's shares. It likes ANZ due to the strength of its institutional business, which has been performing exceptionally well in a difficult environment for the banks.
As for dividends, Goldman is forecasting fully franked dividends per share of $1.62 in both FY 2024 and FY 2025. Based on the current ANZ share price of $25.95, this will mean dividend yields of 6.25% in both years.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Another ASX dividend stock that has been named as a buy is Healthco Healthcare and Wellness REIT.
It is a leading health and wellness focused real estate investment trust that owns a diversified portfolio underpinned by attractive megatrends.
The team at Morgans is positive on the company and has an add rating and $1.67 price target on its shares.
In respect to income, it is forecasting dividends per share of 8 cents in both FY 2024 and FY 2025. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.43, this will mean yields of 5.6% in both years.
Orora Ltd (ASX: ORA)
Goldman Sachs also thinks that this packaging company could be a top ASX dividend stock to buy in January
The broker has a buy rating and $3.55 price target on its shares, which implies over 36% upside for investors.
In addition, it expects so attractive yields from its shares. It is forecasting 13 cents per share dividends for FY 2024, FY 2025, and FY 2026. Based on the current Orora share price of $2.60, this will mean 5% yields for each year.
